SUNHO（China）BioPharmaceutical CO., Ltd.
SUNHO（China）BioPharmaceutical CO., Ltd.
Explore linked clinical trials.10 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric neoplasm, neoplasm, stomach disorder | Recruiting | Phase 2 / Phase 3 | 2026-06-05 | NCT06504732 | |
| First-in-Human Study of ISH0613: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Not yet recruiting | Phase 1 | 2026-04-13 | NCT07516639 | |
| First-in-Human Study of ISH0688: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics | Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, hypertriglyceridemia, metabolic disease | Not yet recruiting | Phase 1 | 2026-04-01 | NCT07505043 | |
| A Phase II/III Study of IBB0979 in Combination With Topotecan Versus Topotecan in Relapsed Small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Not yet recruiting | Phase 2 | 2025-07-21 | NCT07076095 | |
| A Clinical Trial to Evaluate Effect of IBD0333 in Patients With Advanced Malignant Tumors | MTD | Recruiting | Phase 1 / Phase 2 | 2025-01-17 | NCT06292208 | |
| A Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant Tumors | Advanced Malignant Tumors | Recruiting | Phase 1 / Phase 2 | 2025-01-17 | NCT05991583 | |
| A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 / Phase 2 | 2025-01-15 | NCT06581419 | |
| A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Currently Phase II.). | Disease Attributes, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, nasopharyngeal carcinoma, neoplasm, squamous cell carcinoma | Not yet recruiting | Phase 2 / Phase 3 | 2024-12-05 | NCT06719479 | |
| A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors | Advanced Malignant Tumors | Recruiting | Phase 1 / Phase 2 | 2024-02-20 | NCT06223841 | |
| A Study of IAP0971 in Combination With Bacillus Calmette Guerin in High Risk Non-muscular Invasive Bladder Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Not yet recruiting | Phase 1 / Phase 2 | 2024-02-13 | NCT06255964 |